Tissue Sectioning Market is expected to reach US$ 904.86 Million by 2028

Automatic Segment to Lead Tissue Sectioning Market During 2021–2028

According to our latest study on "Tissue Sectioning Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Technology, Application, End User, and Geography," the market is projected to reach US$ 904.86 million by 2028 from US$ 580.29 million in 2021; it is estimated to grow at a CAGR of 6.6% from 2021 to 2028. The report highlights the key factors driving the market and prominent players with their developments in the market. Factors such as increasing prevalence of chronic diseases and rising awareness of personalized medicines are boosting the tissue sectioning market growth. However, the high cost of diagnosis, the lack of skilled professionals, and challenges in the medical device industry hamper the market's growth.

Based on technology, the tissue sectioning market is segmented into automatic, semiautomatic, and manual. The automatic segment would account for the largest market share in 2021. The same segment is expected to register the highest CAGR during the forecast period. The advantages of an automated system compared with traditional manual sectioning are the invariable thickness, uniform orientation, and fewer tissue-sectioning artifacts. Sectioning using an automatic microtome enables many faster features for study and analysis in light microscopy histology, spectroscopy, electron microscopy, and botanical microtomy. Different cutting mode operations like single, interval, multi, and continuous provide high throughput serial sectioning. The rising adoption of automatic microtome in diagnostics, medicine, and other research purposes is expected to drive the tissue sectioning technology segment during the forecast period.

Tissue sectioning is a procedure that involves cutting tissues into thin sections so that they can be placed on a slide and then mounted under a microscope for study. It is used to examine the tissue to detect any abnormalities or disease conditions. It is employed in histology laboratories, science laboratories, and other settings. Frozen sectioning and paraffin sectioning are the two types of tissue sectioning. It is used to detect breast nodules to determine whether a mastectomy is necessary and to treat congenital megacolon in children and newborns.

Thermo Fisher Scientific Inc.; Leica Biosystems Nussloch GmbH; Diapath S.p.A; Histo-Line Laboratories; MEDITE Medical GmbH; SLEE medical GmbH; Abcam plc; Amos Scientific Pty Ltd; Sakura Finetek Europe B.V.; and LLS ROWIAK LaserLabSolutions GmbH are among the leading companies operating in the tissue sectioning market.

Tissue Sectioning Market, by Region, 2021 (%)

---

Tissue Sectioning Market Growth & Opportunity 2021 to 2028

Download Free Sample

---

Tissue Sectioning Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Instruments, Accessories and Consumables, Services); Technology (Automatic, Semiautomatic, Manual) Application (Diagnosis, Research); End-Use (Hospitals, Clinics, Diagnostic Laboratories, Research Centers)

The tissue sectioning market has been segmented as follows:

The tissue sectioning market is segmented based on product, technology, application, end user, and geography. Based on product, the market is further segmented into instruments, accessories & consumables, and services. The instruments segment is further segmented into rotary microtome, sliding microtome, ultra microtome, cryostat, and others. Based on technology, the tissue sectioning market has been segmented into automatic, semiautomatic, and manual. Based on application, the tissue sectioning market has been segmented into diagnosis and research. In terms of end user, the tissue sectioning market has been segmented into hospitals, clinics, diagnostic laboratories, digital path labs, and others. By geography, the market is segmented into North America, Europe, Asia Pacific (APAC), Middle East & Africa (MEA), and South & Central America (SCAM). The tissue sectioning market in North America is segmented into the US, Canada, and Mexico. The tissue sectioning market in Europe is segmented into France, Germany, the UK, Spain, Italy, and the Rest of Europe. The tissue sectioning market in Asia Pacific (APAC) is segmented Into China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific. The tissue sectioning market in the Middle East & Africa (MEA) is segmented Into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. The tissue sectioning market in South and Central America (SCAM) is segmented into Brazil, Argentina, and the Rest of South and Central America.